Abstract
Synthesis and biological evaluation of an spiro[benzoxazepine-piperidine] class of Aβ-peptide production inhibitors for treatment of Alzheimer's disease are described.
Acknowledgements
We are grateful to Professor K. Dudley (Université de la Méditerranée, IBDML) for the preparation of the manuscript.